Norgine B.V. Enters Into Exclusive Licence and Distribution Agreements for the Commercialisation of PLENVU® in a Number of Countries in…
Amsterdam (ots/PRNewswire) - Norgine B.V. (Norgine), a leading European specialist pharmaceutical company, today announced a number of deals for the commercialisation of Norgine's product PLENVU® around the world. Norgine entered into exclusive licence and distribution agreements with:
- Norgine to receive upfront payments, undisclosed milestone payments along with double-digit percentage royalties
- Norgine retains full commercial rights to PLENVU® in all unlicensed countries
* Faes Farma S.A. in Chile, Colombia,!-->…